MedX Health Corp (TSXV:MDX)
Canada · Delayed Price · Currency is CAD | Market Cap | 14.76M -30.1% |
| Revenue (ttm) | 569.79K +19.1% |
| Net Income | -6.19M |
| EPS | -0.02 |
| Shares Out | 327.93M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 200,000 |
| Open | 0.0450 |
| Previous Close | n/a |
| Day's Range | 0.0450 - 0.0450 |
| 52-Week Range | 0.0400 - 0.0700 |
| Beta | 1.76 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Nov 27, 2026 |
About MedX Health
MedX Health Corp develops, manufactures, and markets skin related screening tools and phototherapy devices for pain relief and tissue repair in Canada, the United States, Europe, and internationally. The company offers SIAscopy, a medical device technology used to scan skin for suspicious moles and lesions; and phototherapeutic medical devices, which use light energy in lower-level laser and LED to provide effective treatment of pain and tissue damage in the rehabilitation market. It also provides DermSecure, a telemedicine software application... [Read more]
Financial Performance
In 2025, MedX Health's revenue was 473,266, a decrease of -3.36% compared to the previous year's 489,698. Losses were -6.29 million, 72.2% more than in 2024.
Financial StatementsNews
MedX Health Launches SkinSecure™ to Bring Direct, Non-Invasive, Objective Biological Measurement to Skin Health Research
MISSISSAUGA, Ontario--(BUSINESS WIRE)--MedX Health Corp. (TSXV: MDX) today announced the commercial launch of SkinSecure™, a cloud-based SaaS platform that links the Company's native SIAscope multi-sp...
MedX Announces Final Closing of Non-brokered Private Placement
MISSISSAUGA, Ontario--(BUSINESS WIRE)--MedX Health Corp. (“MedX” or the “Company”) (TSX-V: MDX) is pleased to announce that, further to its Press Release dated April 15, 2026, when it announced applic...
MedX Announces Application for Final Extension of Non-Brokered Private Placement
MISSISSAUGA, Ontario--(BUSINESS WIRE)--MedX Health Corp. (“MedX” or the “Company”) (TSX-V: MDX) is pleased to announce that, further to its Press Release dated March 16, 2026, when it announced applic...
MedX Announces Application for Extension of Non-Brokered Private Placement
MISSISSAUGA, Ontario--(BUSINESS WIRE)--MedX Health Corp. (“MedX” or the “Company”) (TSX-V: MDX) is pleased to announce that, further to its Press Release dated February 27, 2026, when it announced the...
MedX Announces $2,700,000 Initial Closing of Non-Brokered Private Placement of Series IV Convertible Loan Notes
MISSISSAUGA, Ontario--(BUSINESS WIRE)--MedX Health Corp. (“MedX” or the “Company”) (TSX-V: MDX) is pleased to announce that, further to its Press Release dated February 2, 2026, it has surpassed the M...
MedX Announces Non-Brokered Private Placement of Series IV Convertible Loan Notes
MISSISSAUGA, Ontario--(BUSINESS WIRE)--MedX Health Corp. (“MedX” or the “Company”) (TSX-V: MDX) is pleased to announce that it is proposing a non-brokered Private Placement to accredited investors of ...
MedX Health 2025 YEAR REVIEW
MISSISSAUGA, Ontario--(BUSINESS WIRE)--MedX Health Corp. (TSXV: MDX) (“MedX” or the “Company”) is a data-driven health analytics business underpinned by proprietary intellectual property and regulated...
MedX Announces Final Closing of Non-Brokered Private Placement
MISSISSAUGA, Ontario--(BUSINESS WIRE)--MedX Health Corp. (“MedX” or the “Company”) (TSX-V: MDX) is pleased to announce that, further to its Press Release dated October 6, 2025, announcing an Initial C...
MedX announces Initial Closing and Proposed Extension of Non-Brokered Private Placement
MISSISSAUGA, Ontario--(BUSINESS WIRE)--MedX announces Initial Closing and proposed Extension of Offering.
MedX Health Appoints Dr. Symon Cotton as Strategic Advisor on AI & Product Development
MISSISSAUGA, Ontario--(BUSINESS WIRE)--MedX Health Corp. (TSXV: MDX), (“MedX” or the “Company”), a global leader in teledermatology and non-invasive skin analysis, today announced the appointment of D...
MedX Health Appoints Global Skin Science Leader Dr. Paul Matts as Strategic Advisor
MISSISSAUGA, Ontario--(BUSINESS WIRE)--MedX Health Corp. (TSXV: MDX), “MedX” or the “Company”), a global leader in teledermatology and non-invasive skin analysis, today announced the appointment of Dr...
MedX Announces Proposed Extension of Non-Brokered Private Placement
MISSISSAUGA, Ontario--(BUSINESS WIRE)--MedX Health Corp. (“MedX” or the “Company”) (TSX-V: MDX) announced today that, subject to acceptance by the TSX-V, the ultimate Closing Date for the non-brokered...
MedX Health Corp. Names Meghan Geary as Senior Vice President of Operations
MISSISSAUGA, Ontario--(BUSINESS WIRE)--MedX Health Corp. (“MedX” or the “Company”) (TSXV: MDX), the global leader in teledermatology solutions, confirms the appointment of Meghan Geary as the Company'...
MedX Announces Proposed Non-Brokered Private Placement to Raise up to $2,500,000 and Stock Option Grants
MISSISSAUGA, Ontario--(BUSINESS WIRE)--MedX Health Corp. (“MedX” or the “Company”) (TSX-V: MDX) is pleased to announce that it is proposing to raise up to $2,500,000 by way of a Non-Brokered Private P...
MedX Health Corp. Names John Gevisser as Chief Executive Officer
MISSISSAUGA, Ontario--(BUSINESS WIRE)--MedX Health Corp. (“MedX” or the “Company”) (TSXV: MDX), the global leader in teledermatology solutions, confirms the appointment of John Gevisser as the Company...
MedX Announces the Engagement of Market Maker Consultant
MISSISSAUGA, Ontario--(BUSINESS WIRE)--MedX Health Corp. (“MedX” or the “Company”) (TSX-V: MDX) announces today the engagement of Red Cloud Securities Inc. (“Red Cloud”) to provide market making servi...
MedX Announces Further Closing of Non-Brokered Private Placement
MISSISSAUGA, Ontario--(BUSINESS WIRE)--MedX Health Corp. (“MedX” or the “Company”) (TSX-V: MDX) is pleased to announce that, further to its Press Release dated April 7, 2025, announcing an Initial Clo...
MedX Health, Vitamed Biomedical, and Medispa Partner to Expand Teledermatology Services Across Italy
MISSISSAUGA, Ontario--(BUSINESS WIRE)--MedX Health Corp. (“MedX” or the “Company”) (TSXV: MDX), a global leader in teledermatology, is pleased to announce a strategic collaboration in the Italian heal...
MedX Health and Health Partners Sign Commercial Agreement Following Successful UK Pilot
MISSISSAUGA, Ontario--(BUSINESS WIRE)--MedX Health Corp. (“MedX” or the “Company”) (TSXV: MDX), the global leader in teledermatology solutions, is pleased to announce the signing of a commercial contr...
MedX Announces Extension of Non-Brokered Private Placement
MISSISSAUGA, Ontario--(BUSINESS WIRE)--MedX Health Corp. (“MedX” or the “Company”) (TSX-V: MDX) is pleased to announce that, further to its Press Release dated April 7, 2025, when it announced the Ini...
MedX Announces Intention to Seek Acceptance for Amendment to Warrants
MISSISSAUGA, Ontario--(BUSINESS WIRE)---- $MDX #SkinCancer--MedX Health announces its intention to seek acceptance for an amendment to terms for warrants issued in connection with 2020 private placeme...
MedX Health Announces Board Changes
MISSISSAUGA, Ontario--(BUSINESS WIRE)---- $MDX #SkinCancer--MedX Health adds capital investor experience to its Board with the appointment of two new Directors.
MedX Health and PharmaChoice Announce Agreement to Launch MedX Teledermatology Screening Platform Across Canada
MISSISSAUGA, Ontario--(BUSINESS WIRE)---- $MDX #SkinCancer--MedX Health and PharmaChoice announce agreement to launch commercialization pilot project for MedX's DermSecure teledermatology screening pl...
MedX Health Announces Final Closing of Secured Convertible Debenture Financing
MISSISSAUGA, Ontario--(BUSINESS WIRE)---- $MDX #SkinCancer--MedX Health announces final closing of its previously announced Secured Convertible Debentures financing.
MedX Announces First Closing of Secured Convertible Debenture Financing
MISSISSAUGA, Ontario--(BUSINESS WIRE)---- $MDX #SkinCancer--MedX Health announces first closing of Secured Convertible Debenture financing for $765,000.